Countries Taiwan

BioGate Announces Breakthrough in Pancreatic Cancer Treatment with New Drug BGX

Under the leadership of Dr. Frank Huang, Chairman and CEO, BioGate disclosed that their in-house research and development team has engineered BGX by integr...

 March 07, 2024 | News

Caliway's CBL-514 Gains FDA Orphan Drug and Fast Track Designations for Dercum's Disease Treatment

Caliway Biopharmaceuticals (Caliway) announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) to CBL-514 for Dercum...

 March 05, 2024 | News

Synbio Tech's Probiotic TWK10 Earns Taiwan FDA Approval for Anti-fatigue Health Claim

Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious...

 February 19, 2024 | News

Acepodia Gains FDA Clearance for ACE2016, Initiates Phase 1 Study on Solid Tumor Treatment

This clearance marks a significant milestone for Acepodia, allowing the initiation of a Phase 1, first-in-human clinical trial to assess th...

 February 05, 2024 | News

Lumosa Therapeutics and CHI Memorial initiate a new Acute Stroke Study in Taiwan

Stroke, a leading cause of adult disability globally, hits particularly hard in Chattanooga, Tenn., an area known as the "Stroke Belt," with one of th...

 February 02, 2024 | News

Taiwan's Anbogen Secures $12.5M in Series A for Precision Oncology

The lead investor is China Development Industrial Bank (CDIB), with significant contributions from Taian Venture Capital, Maxpro and the National Developme...

 February 01, 2024 | News

Travere Therapeutics Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics,announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endothelin ...

 January 29, 2024 | News

Caliway Receives Initial Approval for CBL-514 Phase 3 Fat Reduction Study

"We are all delighted to see CBL-514 showing its potential to become the new, promising, non-invasive fat reduction treatment in the previous Pha...

 January 24, 2024 | News

Bora Pharmaceuticals Expands Globally with $210 Million Acquisition of Upsher-Smith

BioPharma APAC Perspective: Bora's acquisition of Upsher-Smith for $210 million marks a pivotal moment for the pharmaceutical giant. This strategic move n...

 January 18, 2024 | News

CStone sells to Servier its exclusive rights to TIBSOVO® in Greater China and Singapore

The deal enables CStone to prioritize its resources to focus on the development of first-in-class and best-in-class therapies with global rights. T...

 December 22, 2023 | News

Supercell Secures Exclusive License for Advanced NK Cell Treatment Tech from Japanese Immunotherapy Leader in Taiwan

  The majority of NK cells administered on day 14 are CD56brightCD16-NK cells, which primarily enhance immune function but show reduced expr...

 December 05, 2023 | News

President Tsai Ing-wen Inaugurates Taiwan Healthcare+ Expo 2023, Showcasing Global Leadership in Healthcare Technology

Renowned for expertise in AI, cloud computing, IoT, 5G, and display technology, Taiwan has become a tech hub propelling biomedical progress. The expo, con...

 December 01, 2023 | News

Senhwa Biosciences Granted FDA IND for Phase II Study of Silmitasertib in Viral Community-Acquired Pneumonia (CAP)

The trial is a phase II multi-center, randomized-controlled interventional prospective study, and the purpose of this trial is to investigate whether ...

 November 22, 2023 | News

Taiwan Lubricate for academic research and health products development

In the collaboration with Lipotype GmbH, Germany (the world leader in lipidomics profiling service), T-BAL has developed advanced multi-omics (ma...

 November 20, 2023 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close